Does faster clot removal in ICH give better patient outcomes?

115 Sites to Qualify:
90 Sites to Activate:
500 Participants to Enroll:
  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
  • Bloggers
    Bloggers Search for your favorite blogger from this site.
  • Archives
    Archives Contains a list of blog posts that were created previously.
  • Login
    Login Login form



Please save the date for our

Quarterly MISTIE III Safety Forum

To be held via webinar

Wednesday, January 27th at 1-2pm EST


Registration link: https://attendee.gotowebinar.com/register/6372093564795161858 


Principal Investigator and M3 Neurosurgeon attendance is requested.

Agenda TBD 


Much has been written about the escalating costs, slowing cycle times, and long time-to-publication for clinical trials.[1][2] Despite significant effort to harmonize regulations, develop sophisticated data systems and rethink outmoded practices, transformation in clinical research has been much slower than in other industries.[3]

The first off-the-shelf electronic data capture (EDC) systems emerged in the late 1990’s. Despite demonstrated tangible benefits [4], it took more than 10 years before EDC was widely adopted in the pharmaceutical industry; adoption in academic trials has been even slower.[5]  On the site startup side, some 30% of pharmaceutical and medical device companies, as reported in a 2013 NextDocs survey, were still using paper-based files and only 24% were using a dedicated electronic trial master file (eTMF) system.[6] Adoption of centralized (risk-based) monitoring, adaptive designs and similar business and technological innovations has also been painfully slow.

Certainly, a number of factors come into play, but a core obstacle may be that, by definition, clinical trials involve large numbers of people — and people (or their institutions!) can be highly resistant to change. In an informal 2009 clinical site survey by ClinPage, 26% of 629 respondents, 71% being study coordinators, said EDC data were being initially entered from a paper CRF rather than direct data collection. This is surprisingly worse than the 21% in their earlier 2001 survey. Whether this reflects human cultural hesitation, growing institutional fears (over HIPPA, European Data Directive, etc.), or just the ever increasing complexity of studies, much of the value of an EDC system is lost if its implementation does little more than transfer the task of entering intermediary paper case forms (“data collection worksheets”) from the sponsor to the investigator.[7]

BIOS’ experience with the MISTIE clinical development program is a good example of how transformational technology and business process change can reduce time and cost while improving quality. But, more importantly, it serves as an example of how innovation, to be successful, must be implemented in the context of a well-designed plan executed by a skill project management team.

Continue reading

Please save the date for our

Quarterly MISTIE III Safety Forum

To be held via webinar

Wednesday, September 16th, 1-2pm EDT


Registration link: https://attendee.gotowebinar.com/register/4448979556126173697



MISTIE III Surgical Summary and Lessons Learned

Heparin Use in MISTIE III

Click here for a video recording of the Safety Forum.



We missed Nicki at our MISTIE team meeting this week, but it seems she had a good excuse! She is now a proud new grandmother of a beautiful 5.4 pound little girl named Lili who was born on July 8th.  Congratulations Nicki!


Good news everyone! Inservice training slides are now available in the documents section under Training Files. These are specifically designed to give non-core team members at your site a quick but comprehensive overview of the trial. 


Brain Injury Outcomes

Johns Hopkins University
1550 Orleans Street
CRB-II, 3M50 South
Baltimore, MD 21231 USA
Office:   (410) 614-6996
Fax: (410) 502-7869
24-Hr: (410) 736-1368